The Costs of Disparities in the Treatment of Chronic Lymphocytic Leukemia

Seema Bhat, MD

May 30, 2023

Seema Bhat, MD, comments on the prevalence of racial and ethnic disparities in the diagnosis and treatment of chronic lymphocytic leukemia.

Invoking the multiple factors that contribute to differences in how certain populations experience medical treatment, Dr Bhat notes how available indices, such as the rural urban commuting area (RUCA) codes, show that specific groups are more deeply affected by inequities in access to treatment and imbalances in clinical research.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: The Costs of Disparities in the Treatment of Chronic Lymphocytic Leukemia - Medscape - May 30, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.